Post-Traumatic Stress Disorder Market Overview

Post-Traumatic Stress Disorder is a disease that is generally triggered in human beings when they go through the nightmarish experience. These experiences often include war, sexual assault, mugging, accidents, others. Some people come out of it after a few months but often there are people who witness its impact for a long time. It can turn fatal if not taken measures at the right time. Several other factors like an increase in a number of clinical trials, availability of better medicines, growing initiatives from government and private investors, and others can make sure that the market does not slump. The use of cannabidiol (CBD) for the treatment of Post-Traumatic Stress Disorder (PTSD) can trigger further problems. The global Post-Traumatic Stress Disorder Industry for PTSD may find the growth with few bumps as medicines needed for the treatment is often unavailable in regions. In addition, the market may find the growth to be a bit slackened due to a lack of acknowledgment.

Post-Traumatic Stress Disorder (PTSD) is fast gaining recognition as people have started realizing how it can shape lives. The growing awareness is playing a positive role in taking the global post-traumatic stress disorder market. As per the report published by Market Research Future (MRFR), several factors are there that can directly impact market growth. The post-traumatic stress disorder (PTSD) treatment market can expect to attain a growth rate of 4.8% during the evaluation period (between 2020 and 2027). The global market worth by the end of 2027 should be around USD 1,380 million.

Post-traumatic stress disorder or PTSD is a type of psychological condition, which has an impact on people regardless of their age or gender. Some of the key symptoms of PTSD arise almost immediately post the traumatic experience while others occur over a certain course of time. Some of the symptoms include mood swings, avoiding stressful situations, and more. The prevalence of the condition is statistically more among women. The higher rate of domestic and sexual abuse among the female population worldwide leads to the occurrence of the mental disorder.

Post-Traumatic Stress Disorder Market Segmentation

• The global market for Post-Traumatic Stress Disorder (PTSD) has been studied in the published report of MRFR using segmentation. These segments are treatment and end users. Such segmental analysis gives a deeper look into the market using which the growth would be easier.

• By treatment, the global market for Post-Traumatic Stress Disorder (PTSD) has been segmented in the report into psychotherapy and medication. Psychotherapy requires cognitive-behavioral therapy (CBT) that can reduce the impact of such disorders. The medication segment is the largest one and several drugs are in the pipeline waiting for FDA approval, which can transform the market.
• By end user, the global market for Post-Traumatic Stress Disorder (PTSD) can be segmented into hospitals & clinics, ambulatory surgical centers, and others. Of these, the hospitals & clinics segment is the largest one as a lot of patients suffering from the disease require rehabilitation.

Post-Traumatic Stress Disorder Market Regional Analysis

North America has bagged the leading spot in the worldwide market for post-traumatic stress disorder treatment, given the drastic increase in the number of mental disorders arising from sexual molestation, childhood physical abuse, physical attack, combat exposure, rape, and childhood neglect.

Europes growing prominence in the global market is notable, with the region capturing the second place. The market size in the region has been blossoming on the back of the surge in human right issues such as sexual violence leaving long as well as a short-term impact on the mental health. The significant focus on research and development activities among major companies in the region further bolsters the market value.

As the fastest-progressing market, Asia Pacific benefits from the fast-emerging countries with booming population. China and India stand at the vanguard of the APAC market, thanks to the alarming rise in road accidents coupled with the surge in various traumatic events and more.

Post-Traumatic Stress Disorder Market Players

• Mylan NV (US)
• Greenstone LLC (US)
• Bionomics (Australia)
• Tonix Pharmaceuticals Holding Corp. (US)
• Marinus Pharmaceuticals Inc. (US)
• Azevan Pharmaceuticals (US)
• Lundbeck A/S (Denmark)
• Eli Lily and Company (US)
• Pfizer (US)
• GlaxoSmithKline (UK)

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/post-traumatic-stress-disorder-market-8376

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com